As of 2025-11-05, the Relative Valuation of Chinook Therapeutics Inc (KDNY) is (49.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 40.39 USD, the upside of Chinook Therapeutics Inc based on Relative Valuation is -223.5%.
The range of the Relative Valuation is (49.33) - (50.29) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 14.8x | 14.6x |
| Forward P/E multiples | 14.4x - 14.7x | 14.6x |
| Fair Price | (49.33) - (50.29) | (49.86) |
| Upside | -222.1% - -224.5% | -223.5% |
| Date | P/E |